Viewing StudyNCT00238485



Ignite Creation Date: 2024-05-05 @ 12:04 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00238485
Status: COMPLETED
Last Update Posted: 2017-03-28
First Post: 2005-10-12

Brief Title: An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine 750-2000 mgd in the Treatment of Manic Episodes of Bipolar I Disorder
Sponsor: Novartis
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Bipolar I Disorder
Keywords:
Name View
Bipolar I Disorder View